Pulmonary sarcoidosis
Clinical research includes active pulmonary sarcoidosis, with attention to granulomatous inflammation in the lung parenchyma and the use of FDG PET/CT imaging to assess inflammatory burden.
- Active pulmonary sarcoidosis
- Granulomatous inflammation
- Lung parenchyma
- FDG PET/CT imaging
The sponsor’s work in this area centers on respiratory inflammation and imaging-based evaluation of disease activity.
Solid tumours
Research activity also covers advanced and/or metastatic solid tumours, including colorectal cancer, ovarian cancer, pancreatic cancer, and renal cell carcinoma.
- Advanced and/or metastatic solid tumours
- Colorectal cancer
- Ovarian cancer
- Pancreatic cancer
- Renal cell carcinoma
This field reflects a focus on difficult-to-treat oncological disease with limited therapeutic options.
Oncology safety and antineoplastic activity
The sponsor’s oncology portfolio includes evaluation of antineoplastic activity alongside safety and tolerability in patients with advanced malignancies.
- Antineoplastic activity
- Safety
- Tolerability
- Advanced malignancies
These studies are directed toward treatment approaches for progressive cancer settings.
Multicentre clinical research
Trials are conducted across multicentre settings in multiple countries, involving a network of collaborating research sites in Europe and beyond.
- Multicentre studies
- Research site network
- International trial activity
The research footprint spans both inflammatory disease and oncology across several active jurisdictions.
